Shows
Canadian Urological Association (CUA)Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimensEpisode NotesPodcast Host Disclosures:Dr. Black has received honoraria from AbbVie, Astellas Pharma, AstraZeneca, Bayer, Biosyent, Bristol- Myers Squibb, EMD-Serono, Ferring, Janssen Oncology, Merck, Nanology, Nonagen, Pfizer, Prokarium, Protara, QED, Roche Canada, Sanofi Canada, STIMIT, Urogen Pharma and VerityDr. Lalani has received honoraria from AbbVie, Astellas, AstraZeneca, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen, McKesson, Merck, Novartis, Pfizer, Roche, TerSera. Funding for clinical trials directed to institutions from BMS (Inst), BioCanRx (Inst), Novartis (Inst), Roche (Inst), Ipsen (Inst), EMD Serrono (Inst).Accreditation:This podcast was accredited by...2025-03-0430 min
1001 VasectomiesA qui s'adressent les urologues et vasectomistes quand ils ont une question ?Dans cet épisode de 1001 Vasectomies, le Dr Vincent Hupertan revient d’un séminaire international d’urologues vasectomistes dans le Colorado, aux États-Unis. Pendant plusieurs jours, il a échangé avec des dizaines de collègues, devenus des amis, partageant expériences, techniques et réflexions sur l’avenir de la vasectomie.Au-delà des aspects médicaux, cet épisode met en lumière l’importance du réseau professionnel dans le perfectionnement des pratiques. Comment le partage d’expérience entre spécialistes permet-il d’améliorer les techniques et la prise en charge des patients ? Pourquoi est-il e...2025-02-2514 minCanadian Urological Association (CUA)Canadian Expert discussion on optimizing RCC treatmentEpisode NotesPodcast Host Disclosures:Dr. Choueiri reports institutional and/or personal, paid and/or unpaid support for research, advisory boards, consultancy, and/or honoraria from: Alkermes, AstraZeneca, Aravive, Aveo, Bayer, Bristol Myers-Squibb, Calithera, Circle Pharma, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, Gilead, IQVA, Infinity, Ipsen, Jansen, Kanaph, Lilly, Merck, Nikang, Nuscan, Novartis, Oncohost, Pfizer, Roche, Sanofi/Aventis, Scholar Rock, Surface Oncology, Takeda, Tempest, Up-To-Date, CME events (Peerview, OncLive, MJH, CCO and others), outside the submitted work. Institutional patents filed on molecular alterations and immunotherapy response/toxicity, and ctDNA. Equity: Tempest, Pionyr, Osel, Precede Bio, CureResponse...2023-11-2942 minCanadian Urological Association (CUA)2 Pees In A Pod Podcast - Ep 4 - Introduction to bladder cancerThe fourth episode of the 2 Pees In A Pod Podcast series hosted by Dr Alan So and Dr Claudia Chavez-Munoz. This episode features an introductory discussion on bladder cancer.Do you have questions or a suggestion for a future topic? Email our hosts: 2peesinapodpodcast@gmail.comReferences from the show:Bladder Cancer CanadaDisclaimer: The information provided in this podcast is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health...2023-10-1922 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2022 - Kidney Cancer Session - FrenchProgram Chair: Ricardo RendonKidney Cancer Panelists: Melissa Huynh, Lori Wood Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
2022-10-0143 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2022 - Kidney Cancer Session - EnglishProgram Chair: Ricardo RendonKidney Cancer Panelists: Melissa Huynh, Lori Wood Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
2022-10-0143 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2022 - Bladder Cancer Session - FrenchProgram Chair: Ricardo RendonBladder Cancer Panelists: Peter Black, Maria Jiang Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
2022-10-0141 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2022 - Bladder Cancer Session - EnglishProgram Chair: Ricardo RendonBladder Cancer Panelists: Peter Black, Maria Jiang Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
2022-10-0141 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2022 - Prostate Cancer Session - FrenchProgram Chair: Ricardo RendonProstate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
2022-10-0144 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2022 - Prostate Cancer Session - EnglishProgram Chair: Ricardo RendonProstate Cancer Panelists: Ricardo Rendon, Sebastien Hotte, Scott Morgan Sponsors:Gold: Bristol Myers Squibb, MerckSilver: Astellas, EMD Serono Pfizer, Eisai, IPSEN, Janssen, Seagen
2022-10-0144 minCanadian Urological Association (CUA)Fred Saad | CV Risk | Q&A Series - FrenchFred Saad, MD, FRCSCHUM, Institut de cancer de Montreal/CRCHUM
2022-04-2104 min
Canadian Urological Association (CUA)Darryl Leong | CV Risk | Q&A SeriesDarryl Leong, MDMcMaster University
2022-04-2112 minCanadian Urological Association (CUA)Jean Gregoire | CV Risk | Q&A Series - FrenchJean Gregoire, MD, FRCP(C), FCCS, FACC, FACPUniversity of MontrealInstitut de cardiologie de Montreal
2022-04-2104 min
Canadian Urological Association (CUA)Jean Gregoire | CV Risk | Q&A SeriesJean Gregoire, MD, FRCP(C), FCCS, FACC, FACPUniversity of MontrealInstitut de cardiologie de Montreal
2022-04-2105 min
Canadian Urological Association (CUA)Fred Saad | CV Risk | Q&A SeriesFred Saad, MD, FRCSCHUM, Institut de cancer de Montreal/CRCHUM
2022-04-2105 min
Canadian Urological Association (CUA)Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A SeriesSponsored by Amgen.Luke LavalleeUrologic Oncologist and Associate ScientistThe Ottawa HospitalOttawa Hospital Research InstituteDisclosures:Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, AstellasGrant/Honorarium: Sanofi
2022-04-2007 min
Canadian Urological Association (CUA)Sophie Mottard | Bone Health Management in Prostate Cancer | Q&A SeriesSponsored by Amgen.Sophie MottardOrthopedic Oncology SurgeonMaisonneuve-Rosemont HospitalCHU Saint-Justine and Santa Cabrini HospitalDisclosures:Payment: Amgen (conference speaker)
2022-04-2020 min
Canadian Urological Association (CUA)David Kendler | Bone Health Management in Prostate Cancer | Q&A SeriesSponsored by Amgen.David KendlerEndocrinologist and Clinical ProfessorUBCDisclosures:Advisory Board: Amgen, Paladin, BiosyntSpeakers Bureau: AmgenPayment: Amgen, Biosynt, Radius Pharma, PaladinGrant/Honorarium: Amgen, Biosynt, Radius Pharma, PaladinClinical Trial: Radius PharmaLeadership/Board Position: Specialists of BC, Drs. of BC section of Endocrinology (executive)
2022-04-2015 minCanadian Urological Association (CUA)Why the Tm:Fibre Laser is Superior to the Ho:YAG for Urinary Stones - FrenchDisclosures:Hassan RazviPatent: Cook UrologicalClinical Trials: Boston Scientific, Verity PharmaLeadership/board position: AUA, Endourology SocietyOlivier TraxerConsultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU
2022-04-201h 07Canadian Urological Association (CUA)Why the Tm:Fibre Laser is Superior to the Ho:YAG for Urinary StonesDisclosures:Hassan RazviPatent: Cook UrologicalClinical Trials: Boston Scientific, Verity PharmaLeadership/board position: AUA, Endourology SocietyOlivier TraxerConsultant: Karl Storz, Coloplast, IPG Medical, ROCAMED, Boston Scientific, Quanta, AMBU
2022-04-201h 07Canadian Urological Association (CUA)CUA Highlights of GU ASCO 2022 - Bladder Cancer Session - FrenchDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board PositionNimira AlimohamedAdvisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, SeagenWassim KassoufNo disclosuresAlejandro BerlinNo disclosures
2022-02-2242 minCanadian Urological Association (CUA)CUA Highlights of GU ASCO 2022 - Kidney Cancer SessionDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board PositionChristian KollmannsbergerConsultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, BayerHonoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, BayerScientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, BMS, Janssen, Bayer, Merck
2022-02-2249 minCanadian Urological Association (CUA)CUA Highlights of GU ASCO 2022 - Prostate Cancer SessionDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board PositionTamim NiaziHonoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolmar, Sanofi, FerringKrista NoonanConsultancy-Astellas, AstraZeneca, EMD Serono, Janssen, PfizerRicardo RendonAdvisory Board: Astellas, Amgen, Abbvie, AstraZeneca, Bayer, Ferring, Janssen, Sanofi, TerSeraSpeakers' Bureau: Amgen, Astellas, Bayer, Ferring, Janssen,Grant/Honorarium: Astellas...2022-02-2247 minCanadian Urological Association (CUA)CUA Highlights of GU ASCO 2022 - Prostate Cancer Session - FrenchDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board PositionTamim NiaziHonoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolmar, Sanofi, FerringKrista NoonanConsultancy-Astellas, AstraZeneca, EMD Serono, Janssen, Pfizer Ricardo RendonAdvisory Board: Astellas, Amgen, Abbvie, AstraZeneca, Bayer, Ferring, Janssen, Sanofi, TerSeraSpeakers' Bureau: Amgen, Astellas, Bayer, Ferring, Janssen,2022-02-2247 minCanadian Urological Association (CUA)CUA Highlights of GU ASCO 2022 - Kidney Cancer Session - FrenchDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board PositionChristian KollmannsbergerConsultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, BayerHonoraria for presentations: Pfizer, Ipsen, Eisai, BMS, Janssen, BayerScientific Advisory Board: Pfizer, Novartis, Ipsen, Eisai, Sanofi, Astellas, BMS, Janssen, Bayer, Merck
2022-02-2249 minCanadian Urological Association (CUA)CUA Highlights of GU ASCO 2022 - Bladder Cancer SessionDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board PositionNimira AlimohamedAdvisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, SeagenWassim KassoufNo disclosuresAlejandro BerlinNo disclosures
2022-02-2242 minCanadian Urological Association (CUA)CUA Practice Changing Publications (PCP) - Endourology (Surgical Management of BPH)Disclosures:Dean EltermanAdvisory Boards/ Speakers Bureaus: Astellas, Boston Scientific, Duchesnay, Pfizer, Procept, Prodeon, Olympus, Medtronic, Urotronic, ZeneflowKevin ZornAdvisory Board: BSCI, Procept, Zenflow
2022-02-1558 minCanadian Urological Association (CUA)V2P2 2022 - An Update in Advanced Prostate CancerDisclosures:Fred SaadGrants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, SanofiEleni EfstathiouResearch Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, NuvationScientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
2022-02-101h 01Canadian Urological Association (CUA)V2P2 2022 - An Update in Advanced Prostate Cancer - FrenchDisclosures:Fred SaadGrants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, SanofiEleni EfstathiouResearch Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, NuvationScientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant
2022-02-101h 01Canadian Urological Association (CUA)Practice Changing Publications (PCP): Update in Kidney CancerDisclosures:Anil KapoorAdvisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-ZenecaSpeakers Bureau: Merck, Ipsen, EisaiInvestments: Verity, Point BiopharmaClinical Trials: CCTG, Eisai, Janssen, MerckLeadership/Board Position: Kidney Cancer CanadaLuke LavalleeAdvisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, AstellasGrant/Honorarium: Sanofi
2022-02-011h 02Canadian Urological Association (CUA)The Year Ahead 2022: Global Economic OutlookDisclosures:Derek HendersonBanking relationship with TDChristopher FrenchAdvisory Boards: Astellas, AstraZeneca
2022-01-2457 minCanadian Urological Association (CUA)Practice Changing Publications (PCP): Female UrologyDisclosures:Martine JolivetAdvisory Board and/or Speaker Bureau: Allergan/AbbvieGenevieve NadeauClinical Trials: Contiform InternationalAdvisory Board and/or Speaker Bureau: Pfizer, Boston Scientific, Astellas, Allergan/Abbvie, Searchlight Pharma
2021-12-0751 minCanadian Urological Association (CUA)Management of Medication-Refractory Overactive Bladder (OAB) - FrenchDisclosures:Kevin CarlsonAdvisroy Board/Payment: AbbvieRichard BaverstockAdvisory Board: AbbvieSpeakers Bureau: Astellas, Boston Scientific, AbbviePayment: Abbvie, Astellas, BsciGreg BailyAdvisory Board/ Speaker Bureau: Abbvie
2021-11-241h 10Canadian Urological Association (CUA)Management of Medication-Refractory Overactive Bladder (OAB)Disclosures:Kevin CarlsonAdvisory Board/Payment: AbbvieRichard BaverstockAdvisory Board: AbbvieSpeakers Bureau: Astellas, Boston Scientific, AbbviePayment: Abbvie, Astellas, BsciGreg BailyAdvisory Board/ Speaker Bureau: Abbvie
2021-11-241h 10Canadian Urological Association (CUA)Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (English)Disclosures:Neil FleshnerPayment: Astellas, Janssen, Abbvie, Sanofi, MerckGrant/Honorarium: Astellas, Janssen, BayerInvestments: Verity PharmaClinical Trials: Astellas, Janssen, BayerLeadership Position: Point BiopharmaUrban EmmeneggerAdvisory Boards: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZenecaPayment: Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZenecaGrant/Honorarium: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZenecaClinical Trials: AstraZeneca, Bayer, Clovis, Janssen, Merck, RocheEmily ThainAdvisory Boards: AstraZeneca/Merck, PfizerHonorarium: AstraZeneca/Merck, Pfizer
2021-11-181h 08Canadian Urological Association (CUA)Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (French)Conflits d'interests:Fred SaadSubventions/honoraires: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, SanofiZineb HamilouRemuneration: AstraZeneca, Sengen, EMD SeronoEssai Clinique: SengenEvan WeberSubventions ou des honoraires: AstraZeneca/Merck
2021-11-171h 20Canadian Urological Association (CUA)V2P2 2022 - Female Sexual DysfunctionDisclosures:Ashley CoxAdvisory Board: Abbvie, AllerganRachel S. RubinSpeakers Bureau: SproutClinical Trials: Ipsen, AbbvieLeadership/Board Position: ISSWSH
2021-11-1559 minCanadian Urological Association (CUA)V2P2 2022 - Female Sexual Dysfunction [FR]Disclosures:Ashley CoxAdvisory Board: Abbvie, AllerganRachel S. RubinSpeakers Bureau: SproutClinical Trials: Ipsen, AbbvieLeadership/Board Position: ISSWSH
2021-11-1559 minCanadian Urological Association (CUA)CUA Practice Changing Publications (PCP): TESTIS CANCERDisclosures:Armin AprikianAdvisory boards: Abbvie, Astellas, BayerGrant/Honorarium: Abbvie, Astellas, Bayer, Sanofi, TerSeraRobert HamiltonAdvisory boards: Janssen, Astellas, Bayer, TerSeraClinical Trials: Janssen, Bayer, Astellas
2021-11-021h 00Canadian Urological Association (CUA)CUA Practice Changing Publications (PCP): INFERTILITYDisclosures:Armand ZiniShareholder in YAD Tech - a neutraceuticals companyJesse OryNo disclosures
2021-10-191h 03Canadian Urological Association (CUA)CUA Highlights of ESMO 2021 - Bladder Cancer Session - FrenchDisclosures:Girish KilkarniAdvisory Boards: Janssen, Merck, Roche, Ferring, Astellas, TheralaseGrants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, VerityClinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, PfizerKrista NoonanConsulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD SeronoResearch Support: Roche
2021-09-2229 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2021 - Prostate Cancer SessionDisclosures: Sebastien J. HotteResearch Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChemGrants (Institution): BMS, Janssen, BayerConsultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGenTamim NizaiHonoraria/Research fun: Abbvie, Sanofi, TerSera, Knight Therapeutics, AstraZeneca, Bayer, Astellas, Janssen, Merck, Amgen, AAAAndrea KokorovicNo disclosures
2021-09-2248 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2021 - Bladder Cancer SessionDisclosures:Girish KilkarniAdvisory Boards: Janssen, Merck, Roche, Ferring, Astellas, TheralaseGrants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, VerityClinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, PfizerKrista NoonanConsulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD SeronoResearch Support: Roche
2021-09-2229 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2021 - Kidney Cancer SessionDisclosures: Michael LeveridgeIpsen - speaker session moderator 2019Maryam SoleimaniHonorarium: PfizerGrant funding: Abbvie, Astellas, BayerHimu LukkaNo disclosures
2021-09-2244 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2021 - Kidney Cancer Session - FrenchDisclosures: Michael LeveridgeIpsen - speaker session moderator 2019Maryam SoleimaniHonorarium: PfizerGrant funding: Abbvie, Astellas, BayerHimu LukkaNo disclosures
2021-09-2244 minCanadian Urological Association (CUA)CUA Highlights of ESMO 2021 - Prostate Cancer Session - FrenchDisclosures: Sebastien J. HotteResearch Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChemGrants (Institution): BMS, Janssen, BayerConsultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGenTamim NizaiHonoraria/Research fun: Abbvie, Sanofi, TerSera, Knight Therapeutics, AstraZeneca, Bayer, Astellas, Janssen, Merck, Amgen, AAAAndrea KokorovicNo disclosures
2021-09-2248 minCanadian Urological Association (CUA)CUA Q & A Series | Topic: Delay of InjectionDelay of Injection (Q&A series)0:00 - Ricardo Rendon9:30 - Fred Saad18:10 - Jasper Yuen
2021-07-1326 minCanadian Urological Association (CUA)Milestones in Advanced Bladder CancerPodcast Host Disclosures:Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada.Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche/Genentech, and TerSera; and has received research funding from Bristol-Myers Squibb (Inst), Ipsen, Novartis, and Roche.Accreditation:This podcast was accredited by the Canadian Urological Association in accordance with the Maintenance...2021-07-1227 minCanadian Urological Association (CUA)CUA Highlights of ASCO 2021 - Prostate Cancer Session - FrenchDisclosures:Brita DanielsonHonoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, JanssenNazanin Fallah-RadConsultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeuticsHonorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, MerckTravel Grants: Nekktar TherapeuticsVincent FradetConsultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen, Sanofi
2021-06-0959 minCanadian Urological Association (CUA)CUA Highlights of ASCO 2021 - Kidney Cancer SessionDisclosures:Daniel HengConsultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, IpsenAnand SwaminathAdvisory board: AstrazenecaExpert Speaker: Astrazeneca, BMS, EisaiGrants (in kind): BMS, RocheRodney BreauNo disclosures
2021-06-0952 minCanadian Urological Association (CUA)CUA Highlights of ASCO 2021 - Bladder Cancer session - FrenchDisclosures:Fabio CuryEducational grants: Sanofi S.A., Boston ScientificHonoraria/Travel Support: Varian Medical Systems, Bayer AG, AbbvieNeil FleshnerPayment: Astellas, Janssen, Abbvie, Sanofi, MerckGrant/Honorarium: Astellas, Janssen, BayeyInvestments: Verity PharmaClinical Trials: Astellas, Janssen, BayerLeadership position: Point BiopharmaDi (Maria) JiangSpeaker's honoraria: Ipsen, Janssen, Bayer
2021-06-0959 minCanadian Urological Association (CUA)CUA Highlights of ASCO 2021 - Kidney Cancer Session - FrenchDisclosures:Daniel HengConsultancies and advisory boards: BMS, Merck, Pfizer, Novartis, Eisai, Exilexas, IpsenAnand SwaminathAdvisory board: AstrazenecaExpert Speaker: Astrazeneca, BMS, EisaiGrants (in kind): BMS, RocheRodney BreauNo disclosures
2021-06-0952 minCanadian Urological Association (CUA)CUA Highlights of ASCO 2021 - Prostate Cancer SessionDisclosures:Brita DanielsonHonoraria and speakers fees: Astellas, Amgen, Bayer, Ferring, JanssenNazanin Fallah-RadConsultancy/Advisory: Merck, Ipsen, Pfizer, Nekktar therapeuticsHonorariums: Bayer, Janssen, Ipsen, Astellas, Pfizer, MerckTravel Grants: Nekktar TherapeuticsVincent FradetConsultant, speaker or research agreement: Abbvie, Amgen, Astra Zeneca, Astellas, Bayer, Ferring, Janssen, Sanofi
2021-06-0959 minCanadian Urological Association (CUA)CUA Highlights of ASCO 2021 - Bladder Cancer sessionDisclosures:Fabio CuryEducational grants: Sanofi S.A., Boston ScientificHonoraria/Travel Support: Varian Medical Systems, Bayer AG, AbbvieNeil FleshnerPayment: Astellas, Janssen, Abbvie, Sanofi, MerckGrant/Honorarium: Astellas, Janssen, BayeyInvestments: Verity PharmaClinical Trials: Astellas, Janssen, BayerLeadership position: Point BiopharmaDi (Maria) JiangSpeaker's honoraria: Ipsen, Janssen, Bayer
2021-06-0959 minCanadian Urological Association (CUA)CUA Practice Changing Publications (PCP) in Pediatric UrologyDisclosures:No disclosures
2021-05-061h 01Canadian Urological Association (CUA)CUA Practice Changing Publications (PCP): An Update in Men's HealthDisclosures:Jeffrey CampbellAdvisory Board/Grant/Honorarium: Boston Scientific, Abbvie, Paladin LabsPremal PatelAdvisory Board/Grant/Honorarium: Boston Scientific
2021-04-2853 minCanadian Urological Association (CUA)Practice Changing Publications (PCP): Management of MIBCDisclosures:Girish KilkarniAdvisory Boards: Janssen, Merck, Roche, Ferring, Astellas, TheralaseGrants/Honoraria: Abbvie, Sanofi, Ferring, TerSeraClinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, TheralaseRoss MasonAdvisory Boards: Astellas, Abbvie, TerSara, VerityGrants/Honoraria: Abbvie, Sanofi, TerSara, Bladder Cancer CanadaClinical Trials: Merck, Bayer
2021-04-011h 00Canadian Urological Association (CUA)Practice Changing Publications (PCP): UrolithiasisDisclosures:Andrea G. Lantz PowersnoneBen ChewConsultant: Bard Medical, Boston Scientific, Cook Medical, Olympus, Poly-Med, Adva-TEC inc., Auris Surgical, ColoplastSpeakers Bureau: Boston Scientific, Cook Medical, Olympus, ColoplastGrants: Boston Scientific, Cook Medical, OlympusClinical Trials: Olympus, Bosotn Scientific, Cook Medical
2021-03-011h 01Canadian Urological Association (CUA)Simplifying mCSPC: Improving Patient Management and OutcomesDisclosures:Ricardo RendonAdvisory Board: Astellas, Amgen, Abbvie, Janssen, Bayer, AstraZeneca, Ferring, SanofiSpeakers Bureau: Astellas, Amgen, Ferring, JanssenClinical Trials: Amgen, Astellas, Abbvie, Ferring, Janssen, AstraZeneca, Sanofi, Pfizer, Myovant
2021-02-2440 minCanadian Urological Association (CUA)Practice Changing Publications (PCP) in Functional Urology: A Year in ReviewDisclosures:Ashley CoxAdvisory Board: Astellas, Pfizer, TevaClinical Trial: AquinoxLaura NguyenSpeakers Bureau: Astella, PfizerGrant/Honorarium: Ontario College of Family Physicians
2021-01-261h 00Canadian Urological Association (CUA)Launching the CUA Podcast!The Canadian Urological Association is excited to be launching its new podcast series! Subscribe today to make sure you stay up to date with the latest episodes from CUA – The voice of urology in Canada.
Visit cua.org for more info!2021-01-0200 min
Canadian Urological Association (CUA)Martin Gleave | Early vs Delayed Therapy | Q&A SeriesEarly vs Delayed Therapy - Martin Gleave
2020-12-0509 minCanadian Urological Association (CUA)CUA Q & A Series | Topic: Low T and BreakthroughLow T and Breakthrough (Q&A Series)0:00 - Neil Fleshner1:07 - Martin Gleave4:07 - Mira Keyes9:00 - Laurence Klotz12:32 - Abdenour Nabid16:50 - Tamim Niazi20:55 - Fred Saad23:20 - Bobby Shayegan
2020-12-0530 min
Canadian Urological Association (CUA)Fred Saad | Intermittent vs Continuous Androgen Deprivation in Prostate Cancer | Q&A SeriesIntermittent vs Continuous Androgen Deprivation in Prostate Cancer - Fred Saad
2020-12-0506 min
Canadian Urological Association (CUA)Mira Keyes | Intermittent vs Continuous Androgen Deprivation in Prostate Cancer | Q&A SeriesIntermittent vs Continuous Androgen Deprivation in Prostate Cancer - Mira Keyes
2020-12-0507 min
Canadian Urological Association (CUA)Fred Saad | Early vs Delayed Therapy | Q&A SeriesFred Saad | Early vs Delayed Therapy | Q&A Series
2020-12-0506 minCanadian Urological Association (CUA)CUA Q & A Series | Topic: Early vs Delayed TherapyEarly vs Delayed Therapy (Q&A Series)0:00 - Neil Fleshner3:27 - Martin Gleave11:52 - Mira Keyes21:10 - Laurence Klotz28:40 - Abdenour Nabid37:10 - Tamim Niazi44:05 - Fred Saad49:55 - Bobby Shayegan
2020-12-0559 minCanadian Urological Association (CUA)CUA Q & A Series | Topic: Evolution of LandscapeEvolution of Landscape (Q&A Series)0:00 - Neil Fleshner3:30 - Martin Gleave11:20 - Mira Keyes15:40 - Laurence Klotz20:34 - Abdenour Nabid26:25 - Tamim Niazi33:35 - Fred Saad38:35 - Bobby Shayegan
2020-12-0546 minCanadian Urological Association (CUA)CUA Q & A Series | Topic: Intermittent vs ContinuousIntermittent vs Continuous (Q&A Series)0:00 - Neil Fleshner2:50 - Martin Gleave10:30 - Mira Keyes17:30 - Laurence Klotz24:30 - Abdenour Nabid29:35 - Tamim Niazi35:05 - Fred Saad40:50 - Bobby Shayegan
2020-12-0556 minCanadian Urological Association (CUA)CUA Q & A Series | Topic: Androgen Deprivation TherapyAndrogen Deprivation Therapy (Q&A series)0:00 - Mira Keyes9:53 - Abdenour Nabid14:55 - Tamim Niazi
2020-12-0522 min
Canadian Urological Association (CUA)Abdenour Nabid | ADT Duration with Radiation | Q&A SeriesADT Duration with Radiation - Abdenour Nabid
2020-12-0505 min
Canadian Urological Association (CUA)Laurence Klotz | Early vs Delayed Therapy | Q&A SeriesEarly vs Delayed Therapy - Laurence Klotz
2020-12-0508 min
Canadian Urological Association (CUA)Bobby Shayegan | Low T & Breakthrough | CUA Q&A SeriesBobby Shayegan | Low T & Breakthrough | CUA Q&A Series2020-12-0507 min
Canadian Urological Association (CUA)Neil Fleshner | Low T & Breakthrough | Q&A SeriesLow T & Breakthrough - Neil Fleshner
2020-12-0501 min
Canadian Urological Association (CUA)Laurence Klotz | Low T & Breakthrough | Q&A SeriesLow T & Breakthrough - Laurence Klotz
2020-12-0503 min
Canadian Urological Association (CUA)Tamim Niazi | ADT Duration with Radiation | Q&A SeriesADT Duration with Radiation - Tamim Niazi
2020-12-0508 minCanadian Urological Association (CUA)Qu'est-ce qui rend l'urologie spéciale? (Qu'est-ce que l'urologie)Qu'est-ce qui rend l'urologie spéciale? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-09-0402 minCanadian Urological Association (CUA)À quoi ressemble votre horarie hebdomadaire? (Qu'est-ce que l'urologie)À quoi ressemble votre horarie hebdomadaire? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Quelles qualitiés font un grand urologue? (Qu'est-ce que l'urologie)Quelles qualitiés font un grand urologue? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Où pensez-vous que l'urologie sera dans dix ans? (Qu'est-ce que l'urologie)Où pensez-vous que l'urologie sera dans dix ans? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Quelle est la meilleure partie d'être un urologue? (Qu'est-ce que l'urologie)Quelle est la meilleure partie d'être un urologue? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Pourquoi avez-vous choisi l'urologie comme spécialité? (Qu'est-ce que l'urologie)Pourquoi avez-vous choisi l'urologie comme spécialité? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Y a-t-il un inconvénient à être urologue? (Qu'est-ce que l'urologie)Y a-t-il un inconvénient à être urologue? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Quel est le marché du travail pour les urologues de la prochaine décennie? (Qu'est-ce que l'urologie)Quel est le marché du travail pour les urologues de la prochaine décennie? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Que pensez-vous de l'equilibre entre votre vie professionnelle et votre vie privee? (Qu'est-ce que l'urologie)Que pensez-vous de l'equilibre entre votre vie professionnelle et votre vie privee? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Trouvez-vous que l'urologie donne une carrière enrichissante? (Qu'est-ce que l'urologie)Trouvez-vous que l'urologie donne une carrière enrichissante? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Quel est votre conseil pour un étudiant intéressé par l'urologie? (Qu'est-ce que l'urologie)Quel est votre conseil pour un étudiant intéressé par l'urologie? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-3001 minCanadian Urological Association (CUA)Do you find urology a rewarding career? (What is Urology Series)Do you find urology a rewarding career? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-07-2901 minCanadian Urological Association (CUA)What qualities make a great urologist? (What is Urology Series)What qualities make a great urologist? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-07-2902 minCanadian Urological Association (CUA)What is the best part of being an urologist? (What is Urology Series)What is the best part of being an urologist? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-07-2903 minCanadian Urological Association (CUA)Why did you pick urology as a specialty? (What is Urology Series)Why did you pick urology as a specialty? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-07-2903 minCanadian Urological Association (CUA)What is urology? (What is Urology Series)What is urology? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-07-2210 minCanadian Urological Association (CUA)Qu'est-ce que l'urologie? (Qu'est-ce que l'urologie)Qu'est-ce que l'urologie? (Qu'est-ce que l'urologie). To view the accompanying video of this audio clip please click here.
2020-07-1310 minCanadian Urological Association (CUA)What is your weekly schedule like? (What is Urology Series)What is your weekly schedule like? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-04-1401 minCanadian Urological Association (CUA)Is there a downside to being an urologist? (What is Urology Series)Is there a downside to being an urologist? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-04-1402 minCanadian Urological Association (CUA)What is the job market for urologists in the next decade? (What is Urology Series)What is the job market for urologists in the next decade? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-04-1401 minCanadian Urological Association (CUA)How do you feel about your work life balance? (What is Urology Series)How do you feel about your work life balance? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-04-1402 minCanadian Urological Association (CUA)What makes urology special? (What is Urology Series)What makes urology special? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-04-1402 minCanadian Urological Association (CUA)Where do you think urology will be in ten years from now? (What is Urology Series)Where do you think urology will be in ten years from now? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-04-1402 minCanadian Urological Association (CUA)What is your advice for a student interested in urology? (What is Urology Series)What is your advice for a student interested in urology? (What is Urology Series). To view the accompanying video of this audio clip please click here.
2020-02-0802 min